跳至主要内容
临床试验/NCT04409808
NCT04409808终止不适用

IRIS Alfa Clinical Trial. A Safety Study of a Prototype of a New Vitrectomy Device.

Universitaire Ziekenhuizen KU Leuven2 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2021年9月21日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
39
试验地点
2
主要终点
incidence of intra-operative adverse events that determine the safety of the surgery

研究概览

简要总结

To perform a safety study on the prototype IRIS vitrectomy device.

详细描述

to determine the safety and effectiveness of the device.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients that are scheduled for vitrectomy surgery, regardless of the indication
  • Both vitrectomy-only and combined phaco-vitrectomy surgeries
  • Primary or repeat vitrectomy
  • General or local anesthesia, or combination
  • Informed consent (from parents in patients <18 years old)

排除标准

  • Unable to obtain informed consent from patient (or from parents in children)
  • No post-operative 8 week visit is anticipated

结局指标

主要结局

incidence of intra-operative adverse events that determine the safety of the surgery

时间窗: Intraoperative (surgery day)

complications VTX: iatrogenic tear, lens touch, choroidal/subretinal/vitreous hemorrhage, infusion suprachoroidal, iatrogenic retina trauma, posterior capsule tear, corneal eptihelial damage, hyphema, corneal edema, iris trauma, nucleus fragment in vitreous, posterior capsule tear, retinal incarceration, zonulae rupture with vitreous prolapse, subretinal PFCL, suprachoroidal silicone oil, zonulae dialysis, lens exchange required, other IOL problem

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验